GAMBIA-L Archives

The Gambia and Related Issues Mailing List

GAMBIA-L@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
MOMODOU BUHARRY GASSAMA <[log in to unmask]>
Reply To:
The Gambia and related-issues mailing list <[log in to unmask]>
Date:
Mon, 17 Jul 2000 17:01:49 +0200
Content-Type:
text/plain
Parts/Attachments:
text/plain (47 lines)
Hi!
    Another forward. Enjoy.
                                                                                            Buharry.
____________________________________________________________________
A Reappraisal of the HIV/AIDS Hypothesis
by Michael Baumgartner, Alex Russell and Michael Verney-Elliott 

In 14 years, ĪHIVā has still not been proven to be the cause of the 29 ĪAIDSā defining illnesses. The ĪHIVā hypothesis has been unproductive and non-predictive because ĪAIDSā is neither an infectious epidemic nor caused by ĪHIV.ā 

To date, ĪHIVā has never been isolated as a unique, exogenous Īretrovirus.ā Dr. Robert Gallo and Prof. Luc Montagnier, the alleged co-discoverers of ĪHIV,ā did not follow the rules and standard protocols designed for Īretroviralā isolation set out in 1973 by the Pasteur Institute of France (see Sinoussi in Spectra 4, 1973): The steps for Īretroviralā isolation are: 

  1.. Culture of putatively infected tissue, 
  2.. Purification of specimens by density gradient ultracentrifugation, 
  3.. Electro micrographs of particles exhibiting the morphological characteristics÷having condensed inner bodies (cores) and knobs÷and dimensions÷almost spherical; in shape and in a diameter of 100 - 120 nM÷of retroviral particles at the sucrose density of 1.16 gm/ml and containing nothing else, not even particles of other morphologies or dimensions. 
  4.. Proof that the particles contain reverse transcriptase, 
  5.. Analysis of the particlesā proteins and RNA and proof that these are unique, 
  6.. Proof that points 1 to 5 are property only of putatively infected tissues and cannot be induced in control cultures. 
  7.. Proof that the particles are infectious, that is, when PURE particles are introduced into an uninfected culture or animal, the identical particle is obtained as shown by repeating steps 1 to 5. 
There will never be a cure or a vaccine against ĪHIVā because it does not exist as a unique Īexogenous lentivirus.ā There is no Universal Gold Standard ĪHIVā test to prove ĪHIVā positivity. The ĪHIVā antibody test does not detect a Īvirusā but an assortment of proteins that are non-specific to the hypothetical ĪHIV.ā In Current Medical Research and Opinion, vol. 13, no. 10, August, 1997, and Bio/Technology, June, 1993, ĪAIDSā-analyst and biophysicist, Dr. Eleni Eleopulos and colleagues exposed the non-specificity and unreliability of the ĪHIVā antibody test. Dr. Eleopulosās critique supports the argument for the international banning of the ĪHIVā antibody tests. 

It was admitted ten years ago that there is no such thing as a typical ĪHIVā isolate, therefore, there can be no Gold Standard ĪHIVā test because there is no Gold Standard ĪHIVā isolate. On each continent there are different criteria for ĪHIVā positivity and ĪAIDSā definition. All evidence of ĪHIVā positivity must be confirmed by pure culturing of a patientās lymphocytes and detection of whole, cell-free viral particles; so far this has never been achieved. ĪHIV,ā like all known Īlentivirusesā is not known to be sexually transmitted: cell-free viral particles have never been found directly in semen. Therefore ĪHIVā is not a typically sexually transmitted entity; no Īlentivirusā is. Epidemiologists claim that a degree of correlation between ĪHIVā and ĪAIDSā proves causation. However, just as correlation does not prove causation, epidemiology cannot prove etiology. 

Far from defeating ĪAIDS,ā the ĪHIVā hypothesis has escalated the epidemic by the global promotion of Īantiviralā drugs (AZT, ddI, ddC, 3TC, etc.) which are proven to be a major cause of ĪAIDSā conditions. By focusing exclusively on ĪHIV,ā researchers, counselors and doctors have failed to examine and halt the recreational drug-driven ĪAIDSā epidemic that has hit London, New York, Paris, San Francisco, Amsterdam as well as countries like the former Soviet Union, the Ukraine, Romania, Thailand, Myanmar, Laos, Vietnam and Korea. The ĪAIDSā epidemic reveals that ĪAIDSā would be entirely preventable and in part curable, if: 

  1.. AZT, protease inhibitors and all other Īantiviralā drugs and ĪHIVā vaccines were banned, 
  2.. a global educational programme were instigated concerning the health risks of illicit recreational drugs, 
  3.. and the non-specific ĪHIVā antibody testing procedures (Elisa, Western blot) were to be withdrawn. Therefore patients may be treated for any Īrealā illnesses rather than for the being Ītreatedā by cyto-toxic Īantiviralā drugs on the outcome of an arbitrary ĪHIVā antibody test. 
Yet there are a number of obstacles, 15 years in the making, that block the possible solution of ĪAIDSā based on the drug/āAIDSā hypothesis: 

  1.. The World Health Organization, the Centers for Disease Control, the National Institutes of Health, plus thousands of ĪAIDSā organizations (as well as scientific reputations) focus exclusively on promoting the ĪHIVā hypothesis. 
  2.. The colossal commercial interests in ĪHIVā tests, with over 20 million tests per year at $50 or more in the USA alone. 
  3.. As well as the huge financial profits from ĪHIVā vaccines and anti-āHIVā drugs. Figures published in early August, 1997, of the half-yearly accounts of pharmaceutical giant Glaxo-Welcome showed the multinationalās drugs sales of AZT (Retrovir) and 3TC (Epivir) exceeded £4 billion for the half year. With vast profits like these, Īanti-HIVā drug manufacturers want to hold onto the ĪHIVā hypothesis at all costs. 
  4.. The numerous negligence and malpractice law suits against the ĪHIV/AIDSā orthodoxy from those who were told they are destined to die based on the fraudulent ĪHIVā tests or whose friends/relatives died from iatrogenic-āAIDSā (ĪAIDSā caused by Īantiviralā drugs). 
  5.. The prospect of a profound loss of confidence of the global community in its medical-scientific institutions once the worldās media expose the ĪHIVā fraud. 
  6.. Annually $8 billion are spent on ĪHIVā treatment, research and education on the unproductive ĪHIVā hypothesis paid for by the US taxpayer. The US Government cannot afford to admit at this late stage that they have made a tragic blunder and wasted $46 billion in 14 years. Continuum urgently request that the United Nations to instigate an enquiry into a full reappraisal of the ĪHIV/AIDSā hypothesis under an international, independent scientific committee. 
References:
Eleni Eleopulos, et al., ćIs a Western blot proof of HIV infection?äBio/Technology, June, 1993. Peter Duesberg and David Rasnick, ćThe Drug-AIDS Hypothesis,ä Continuum, vol. 4, no. 5, 1997. 

Copyright 1997: Alex Russell, Michael Verney-Elliott, Michael Baumgartner, Continuum. 

----------------------------------------------------------------------------

To unsubscribe/subscribe or view archives of postings, go to the Gambia-L
Web interface at: http://maelstrom.stjohns.edu/archives/gambia-l.html

----------------------------------------------------------------------------

ATOM RSS1 RSS2